Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 27,382 | 31,543 | 23,550 | 23,291 | 14,975 |
| Operating Income | -27,382 | -31,543 | -23,550 | -23,291 | -14,975 |
| Interest Expense | 30 | 35 | 35 | 37 | 50 |
| Other Income | 1,488 | 2,089 | 2,347 | 1,646 | 837 |
| Pre-tax Income | -25,924 | -29,489 | -21,238 | -21,682 | -14,188 |
| Net Income Continuous | -25,924 | -29,489 | -21,238 | -21,682 | -14,188 |
| Net Income | $-25,924 | $-29,489 | $-21,238 | $-21,682 | $-14,188 |
| EPS Basic Total Ops | -0.79 | -0.89 | -0.64 | -0.77 | 19.84 |
| EPS Basic Continuous Ops | -0.78 | -0.89 | -0.64 | -0.77 | 19.84 |
| EPS Diluted Total Ops | -0.79 | -0.89 | -0.64 | -0.77 | 19.84 |
| EPS Diluted Continuous Ops | -0.78 | -0.89 | -0.64 | -0.77 | 19.84 |
| EPS Diluted Before Non-Recurring Items | -0.78 | -0.89 | -0.64 | N/A | N/A |
| EBITDA(a) | $-27,330 | $-31,460 | $-23,473 | $-23,222 | $-14,898 |